Skip to main content
. 2022 Mar;11(3):386–396. doi: 10.21037/tau-21-1015

Figure 2.

Figure 2

The change of clinical serum marker of renal function in 141 patients after tyrosine-kinase inhibitor (TKI) treatment. After TKI treatment, estimated glomerular filtration rate (eGFR) decreased (A), while serum creatinine (SCr), blood urea nitrogen (BUN), cystatin C (CYSC) all increased (B-D).